ChuH.Y., ChuP., LinY.F., ChouH.K., LinS.H.Uremic tumoral calcinosis in patients on peritoneal dialysis: clinical, radiologic, and laboratory features.Perit Dial Int2011; 31: 430–9.
2.
MaioliM.E., DelfinoV.D.A., GuerraA.C.D.Z., KuniiL.F., FrangeR.F.N.Reversal of uremic tumoral calcinosis by optimization of clinical treatment of bone and mineral metabolism disorder.J Bras Nefrol2017; 39(2): 217–9.
3.
PereiraL., MengC., MarquesD., FrazaoJ.Old and new calcimimetics for treatment of secondary hyperparathyroidism: impact on biochemical and relevant clinical outcomes.Clin Kidney J2018; 11(1): 80–8.
4.
RobinsonM.R., AugustineJ.J., KormanN.J.Cinacalcet for the treatment of calciphylaxis.Arch Dermatol2007; 143(2): 152–4.
5.
VanovskiO., NikolovI.G., JokiN., CaudrillierA., PhanO., MentaverriR.The calcimimetic R-568 retards uremia enhanced vascular calcification and atherosclerosis in apolipoprotein E deficient (apoE-/-) mice.Atherosclerosis2009; 205(1): 55–62.
6.
KawataT., NaganoN., ObiM., MiyataS., KoyamaC., KobayashiN.Cinacalcet suppresses calcification of the aorta and heart in uremic rats.Kidney Int2008; 74(10): 1270–7.
